A really worrying part for me (among others) in the quarterly is the drop in European centers. In the last quarterly 26 centers in Europe and 23 in US were reported.
Now we have 38 in US (as from reported increase of 15) and a total of 60.
This means 22 centers in Europe which is a drop of 4.
Although I still believe the company will deliver I have to say I am really disappointed with the quarterly. I would dare to use the word "record" eventhough regarding the Cardiocel sales it was factually correct.
Quarterly, page-155
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.91 |
Change
-0.090(0.50%) |
Mkt cap ! $341.1M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.75 | $74.32K | 4.151K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 681 | $17.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.25 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |